Two Sigma Advisers
RVMD icon

Two Sigma Advisers’s Revolution Medicines RVMD Stock Holding History

Two Sigma Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-287,646
Closed -$22.9M – 1735
2025
Q4 		$22.9M Buy
287,646
+248,655
+638% +$16.3M 0.04% 321
2025
Q3 		$1.82M Buy
+38,991
New +$1.53M ﹤0.01% 1176
2024
Q4 		– Sell
-30,866
Closed -$1.4M – 2499
2024
Q3 		$1.4M Sell
30,866
-15,156
-33% -$660K ﹤0.01% 1256
2024
Q2 		$1.79M Sell
46,022
-5,969
-11% -$223K ﹤0.01% 1246
2024
Q1 		$1.68M Sell
51,991
-13,800
-21% -$409K ﹤0.01% 1315
2023
Q4 		$1.89M Buy
65,791
+12,691
+24% +$305K ﹤0.01% 1313
2023
Q3 		$1.47M Sell
53,100
-22,700
-30% -$673K ﹤0.01% 1354
2023
Q2 		$2.03M Sell
75,800
-99,900
-57% -$2.45M 0.01% 1195
2023
Q1 		$3.81M Sell
175,700
-3,900
-2% -$96K 0.01% 944
2022
Q4 		$4.28M Sell
179,600
-10,700
-6% -$228K 0.01% 848
2022
Q3 		$3.75M Buy
190,300
+83,100
+78% +$1.83M 0.01% 876
2022
Q2 		$2.09M Sell
107,200
-22,800
-18% -$444K 0.01% 1191
2022
Q1 		$3.32M Buy
130,000
+44,500
+52% +$969K 0.01% 994
2021
Q4 		$2.15M Buy
85,500
+19,600
+30% +$552K 0.01% 1153
2021
Q3 		$1.81M Buy
65,900
+56,200
+579% +$1.64M ﹤0.01% 1309
2021
Q2 		$308K Buy
9,700
+5,000
+106% +$175K ﹤0.01% 2133
2021
Q1 		$216K Buy
+4,700
New +$211K ﹤0.01% 2338

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Advisers's RVMD Position: Q1 2026 in Review

Two Sigma Advisers sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 287,646 shares — an estimated $22.9M sold.

Two Sigma Advisers first reported a position in RVMD in Q1 2021 and held it in 17 quarters. The position peaked at $22.9M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Two Sigma Advisers reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 287,646 Revolution Medicines shares in Q1 2026, an estimated $22.9M.
  • Two Sigma Advisers first reported a position in Revolution Medicines in Q1 2021 and held it in 17 quarters.
  • Two Sigma Advisers's Revolution Medicines position peaked at $22.9M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.